WallStreetZenWallStreetZen

NASDAQ: DYAI
Dyadic International Inc Stock Forecast, Predictions & Price Target

Analyst price target for DYAI

Based on 1 analyst offering 12 month price targets for Dyadic International Inc.
Min Forecast
$6.00+300%
Avg Forecast
$6.00+300%
Max Forecast
$6.00+300%

Should I buy or sell DYAI stock?

Based on 1 analyst offering ratings for Dyadic International Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DYAI stock forecasts and price targets.

DYAI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-13

1 of 1

Forecast return on equity

Is DYAI forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.42%

Forecast return on assets

Is DYAI forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

DYAI revenue forecast

What is DYAI's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$4.3M+48.34%
Avg 2 year Forecast
$6.1M+110.43%
DYAI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DYAI revenue growth forecast

How is DYAI forecast to perform vs Biotechnology companies and vs the US market?
Company
136.33%
Industry
37.5%
Market
10.08%
DYAI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DYAI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DYAI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DYAI$1.50$6.00+300.00%Buy
CLNN$0.34$6.00+1,680.42%Strong Buy
AADI$1.78$20.50+1,051.69%Strong Buy
IMRX$1.50$13.40+793.33%Buy
BLRX$0.61$21.00+3,325.77%Buy

Dyadic International Stock Forecast FAQ

Is Dyadic International Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: DYAI) stock is to Buy DYAI stock.

Out of 1 analyst, 0 (0%) are recommending DYAI as a Strong Buy, 1 (100%) are recommending DYAI as a Buy, 0 (0%) are recommending DYAI as a Hold, 0 (0%) are recommending DYAI as a Sell, and 0 (0%) are recommending DYAI as a Strong Sell.

If you're new to stock investing, here's how to buy Dyadic International stock.

What is DYAI's revenue growth forecast for 2024-2025?

(NASDAQ: DYAI) Dyadic International's forecast annual revenue growth rate of 136.33% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Dyadic International's revenue in 2024 is $2,898,806.On average, 2 Wall Street analysts forecast DYAI's revenue for 2024 to be $124,588,652, with the lowest DYAI revenue forecast at $121,691,241, and the highest DYAI revenue forecast at $127,486,062.

In 2025, DYAI is forecast to generate $176,742,041 in revenue, with the lowest revenue forecast at $176,742,041 and the highest revenue forecast at $176,742,041.

What is DYAI's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: DYAI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is DYAI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year DYAI price target, the average DYAI price target is $6.00, with the highest DYAI stock price forecast at $6.00 and the lowest DYAI stock price forecast at $6.00.

The Wall Street analyst predicted that Dyadic International's share price could reach $6.00 by Nov 13, 2024. The average Dyadic International stock price prediction forecasts a potential upside of 300% from the current DYAI share price of $1.50.

What is DYAI's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: DYAI) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.